Invited Faculty
  • Richard Furie
    Northwell Health
    USA
  • Dr. Richard Furie, Chief of the Division of Rheumatology at Northwell Health, is a rheumatologist whose activities for the last several decades have focused on patient care, physician education, and clinical research in the area of anti-rheumatic drug development. He directs The Program in Novel Therapeutics, the Health System’s clinical research program in musculoskeletal disease. He also directs the Hospital’s SLE and Autoimmune Disease Treatment Center, which has become internationally recognized for its role in the development of new therapies for SLE. Regarded as one of the senior rheumatologists in the New York metropolitan area, he has served as a volunteer for the Arthritis Foundation, the Lupus Foundation of America, the Lupus Research Alliance, and Lupus Therapeutics. For over twenty years he served on many committees of the American College of Rheumatology and was named a Master of the College in 2018. Although often featured as a speaker at national and international conferences, Dr. Furie’s favorite educational venue is at home with his colleagues and trainees.
    Research & Clinical Focus

    patient care

    clinical trial design

    clinical trial implementation

    • Date Time Room Session Title Lecture Title
    May 19 13:40-14:00 Room Grand Ballroom 101 [Concurrent Session 6] New Treatments Targeting B cells/plasma cells in SLE
    May 20 08:00-08:40 Room Grand Ballroom 105 [Breakfast Symposium 12 - Kezar Life Sciences] Zetomipzomib: A Novel Approach in Lupus Nephritis Selective immunoproteasome inhibition with Zetomipzomib for the treatment of lupus nephritis: Review of the open-label mission study results